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ABSTRACT
Objectives: This study aimed to estimate the incidence of maternal near-miss (MNM) morbidity in a tertiary hospital set-
ting in Turkey.
Material and methods: In this retrospective study, we concluded 125 MNM patients who delivered between January 
2017 and December 2017 and fulfilled the WHO management-based criteria and severe pre-eclamptic and HELLP patients 
which is the top three highest mortality rates due to pregnancy. Two maternal death cases were also included. The indicators 
to monitor the quality of obstetric care using MNM patients and maternal deaths were calculated. Demographic charac-
teristics of the patients, the primary diagnoses causing MNM and maternal deaths, clinical and surgical interventions in 
MNM patients, shock index (SI) value of the patients with obstetric hemorrhage and maternal death cases were evaluated.
Results: The MNM ratio was 5.06 patients per 1000 live births. Maternal mortality (MM) ratio was 8.1 maternal deaths per 
100 000 live births. SMOR was 5.14 per 1000 live births. The MI was 1.57%, and the MNM/maternal death ratio was 62.4:1.  
The SI of MNM patients with obstetric hemorrhage was 1.36 ± 0.43, and the SI of the patient who died due to PPH was 1.74.
Conclusions: The MNM rates and MM rates in our hospital were higher than high-income countries but were lower than in 
low- and middle-income countries. Hypertensive disorders and obstetric hemorrhage were the leading conditions related to 
MNM and MM. However, the MIs for these causes were low, reflecting the good quality of maternal care and well-resourced 
units. Adopting the MNM concept into the health system and use as an indicator for evaluating maternal health facilities 
is crucial to prevent MM. 
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INTRODUCTION
Maternal mortality (MM) is still unacceptably high and 
remains a public health problem worldwide. It was reported 
that approximately 830 women die every day due to pre-
ventable causes related to pregnancy and childbirth-related 
complications, and the majority of these deaths occur in low- 
and middle-income countries [1]. Following the United Na-
tions Millenium Development Goals signed in 2005, the goal 
of ‘improving maternal health’, which aims to reduce MM 
by 75% between 1990 and 2015, has been determined [2]. 
The number of maternal deaths, which was 390 000 in 1990, 
was 275 000 in 2015 with a decrease of 30% [3]. Although 
this target could not be met, it was stated that the reduction 
in maternal mortality has accelerated in many countries of 
the world after 2005. In Turkey, the maternal mortality rate 
was reported as 38.3 per 100 000 live births in 2005 and 
14.7 per 100 000 live births in 2015 [4]. This remarkable 
improvement has been associated with several factors, such 
as increased birth rates in healthcare facilities, more avail-
able access to antibiotics and blood products, increased 
education and socioeconomic prosperity of women, and 
improvements in the provision of health care. 
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The Sustainable Development Goals (SDGs), which 
adopted by all United Nations Member States in 2015, has 
the purpose of ending preventable maternal death by re-
ducing the MM ratio by two-thirds by 2030 [5]. Since ma-
ternal deaths are rare even in facilites with comparatively 
high MM, the number of deaths is frequently insufficient to 
assess interventions aiming to improve maternal outcomes 
[6]. Also, maternal deaths are considered the ‘tip of an ice-
berg’ of severe maternal morbidity, in that for every women 
who dies many more women will survive serious pregnancy 
complications [7]. Therefore, maternal morbidity is a com-
ponent of continuity that may reach from good maternal 
health to MM. In 2009, the WHO recommended the concept 
of maternal near-miss (MNM) for assessing the quality of 
maternal care for life-threatening pregnancy complications 
[8]. MNM patients have similar demographic characteristics 
and pathological processes as maternal deaths, with the 
advantages of giving a more significant number of cases 
for analysis, higher acceptability of individuals and facilities 
since death did not occur, and the opportunity of question-
ing the patient herself [9]. 
The WHO defined an MNM patient as a woman who 
nearly died but survived a complication that occurred dur-
ing pregnancy, childbirth or within 42 days of termination 
of pregnancy [10]. Also, the WHO developed a tool to iden-
tify MNM patients. However, routine implementation and 
broader utilisation of the MNM concept as a standard tool 
for developing maternal care has been limited due to the 
lack of a standard description and unique case-identification 
criteria. There are three distinct approaches to identifying 
MNM: clinical criteria related to a specific disease entity, 
intervention-based criteria, and organ system dysfunction 
based criteria (Tab. 1) [10]. Depending on the region and the 
specific criteria used, the prevalence of MNM ranges from 
0.5% to more than 40% of all live delivery hospitalizations 
[11]. However, there is currently no central database for 
MNM patients in Turkey.
This study aimed to estimate the incidence of MNM 
morbidity in a tertiary hospital setting in Turkey.
MATERIAL AND METHODS
We concluded 125 MNM patients who delivered at 
Department of Obstetrics and Gynecology of Diyarbakır 
Gazi Yaşargil Training and Research Hospital between 
January 2017 and December 2017 and fulfilled the WHO 
management-based criteria and severe pre-eclamptic and 
HELLP patients which is the top three highest mortality 
rates due to pregnancy [12, 13]. Two maternal death cases 
were also included. Our hospital is a tertiary center and 
about 25,000 deliveries per year occurred. The local ethical 
committee approved this retrospective study. Data were 
collected from our clinical database. 
All patients were followed up in the intensive care unit 
(ICU) of the hospital. Patients who fulfilled the WHO manage-
ment-based based criteria for MNM, severe pre-eclamptic 
patients and patients with HELLP syndrome were enrolled. 
In the WHO clinical criteria, pre-eclamptic patients with 
jaundice were classified [12]. Otherwise, we included severe 
pre-eclamptic patients because severe pre-eclampsia could 
be complicated. It should be a critical factor for MNM cases 
in obstetric practice, and it is a potentially life-threatening 
condition. Mild pre-eclampsia, mild hemorrhage, and other 
patients who did not meet the WHO criteria were excluded.
Patient characteristics including age, parity, the ges-
tational week at birth, previous cesarean section history, 
mode of delivery, the primary diagnoses causing MNM and 
Table 1. The WHO MNM criteria
Clinical criteria Laboratory-based criteria Management-based criteria
Shock pH < 7.1 (severe acidosis) Cardio-pulmonary resuscitation (CPR)
Gasping PaO2/FiO2 < 200 mmHg Continuous use of vasoactive drugs
Acute cyanosis Lactate > 5 Dialysis for acute renal failure
Clotting failure Oxygen saturation < 90% for ≥ 60 minutes Transfusion of ≥ 5 units of red blood cells
Respiratory rate > 40/min (severe tachypnea) 
or < 6/min (severe bradypnea)
Loss of consciousness and the presence of 
ketoacids in urine 
Intubation and ventilation for ≥ 60 minutes 
not related to anaesthesia  
Oliguria non-responsive to fluids or diuretics Creatinine ≥ 300 µmol/L or ≥ 3.5mg/dL Hysterectomy due to infection or hemorrhage
Loss of consciousness lasting ≥ 12 hours Bilirubin >100 µmol/L or > 6.0 mg/dL
Loss of consciousness and absence of heart 




Jaundice in the presence of preeclampsia
WHO — World Health Organization
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Table 2. The indicators to monitor the quality of obstetric care using 
maternal near-miss patients and maternal deaths
Indicators
Total deliveries, n 25 088
Live births, n 24 693
MNM patients, n 125
Maternal deaths, n  2
MNM ratio, per 1000 live births 5.06
MM ratio, per 100 000 live births 8.1
SMOR, per 1000 live births 5.14
MI, % 1.57
MNM/maternal death ratio 62.4:1
SMOR — severe maternal outcome ratio; MI — mortality index; MNM 
— maternal near-miss
Table 3. Demographic characteristics of the patients
MNM patients  
(n = 125)
Maternal 
deaths (n = 2)
Maternal age, n (%)
≤ 18 years 1 (0.8%)
19–34 years 88 (70.4%)




≥ 5 8 (6.4%) 2 (100%)
Gestational week, n (%)
≥ 34 w 72 (57.6%)
< 34 w 53 (42.4%) 2 (100%)
Previous cesarean, n (%)
No 79 (63.2%) 2 (100%)
Yes 46 (36.8%)
Mode of delivery, n (%)
Vaginal 43 (34.4%) 1 (50%)
Cesarean 82 (65.6%) 1 (50%)
MNM — maternal near-miss
maternal death, requiring clinical and surgical interventions, 
length of ICU stay, and length of hospital stay were recorded. 
The indicators to monitor the quality of obstetric care using 
MNM patients and maternal deaths were calculated.
Women with life-threatening conditions (WLTC) refer to 
all women who either qualified as having MNM or who died 
(WLTC = MNM + MD). MNM incidence ratio refers to the num-
ber of MNM cases per 1,000 live births (MNM IR = MNM/LB). 
MM ratio refers to the number of maternal death cases per 
100 000 live births. Severe Maternal Outcome Ratio (SMOR) 
refers to the number of women with life-threatening condi-
tions per 1,000 live births [SMOR = (MNM + MD)/LB]. Mortal-
ity index refers to the number of maternal deaths divided 
by the number of patients with life-threatening conditions 
[MI = MD/(MNM + MD)]. Shock index (SI) defined as the ratio 
of pulse to systolic blood pressure [14]. 
Statistical analyses
IBM SPSS 21.0 for Windows (SPSS Inc., Chicago, IL, USA) 
statistical package program was used for statistical evaluation 
of our research data. A descriptive analysis of the records was 
performed following completion of the audit. Continuous vari-
ables were presented as mean±standard deviation. Categori-
cal variables were presented as frequencies and percentage.
RESULTS
During the study period, there were 25 088 deliveries 
and 24 693 live births in our hospital. A total of 125 MNM 
patients and two maternal deaths in the intensive care unit 
were identified. Therefore, there were 127 women with 
life-threatening conditions. The indicators to monitor the 
quality of obstetric care using MNM patients and mater-
nal deaths are summarized in Table 2. The MNM ratio was 
5.06 patients per 1000 live births. MM ratio was 8.1 maternal 
deaths per 100 000 live births. SMOR was 5.14 per 1000 live 
births. The MI was 1.57%, and the MNM/maternal death 
ratio was 62.4:1. 
Demographic characteristics of the MNM patients and 
maternal death cases are summarized in Table 3. The mater-
nal age of 70.4% of MNM patients ranged from 19–34 years, 
and 78.4% of MNM patients had parity between 1–4. De-
liveries of 65.6% of the MNM patients were performed by 
cesarean section.
The primary diagnoses causing MNM and maternal 
deaths are summarized in Table 4. Severe pre-eclampsia, 
obstetric hemorrhage and HELLP were the most common 
primary diagnoses causing MNM, valuing for 54 (43.2%), 
58 (46.4%), and 9 (7.2%), respectively. Less frequent diag-
noses causing MNM were eclampsia and status epilepticus, 
valuing for 3 (2.4%), and 1 (0.8%), respectively. The diagnoses 
of maternal death cases were obstetric hemorrhage (one 
patient) and severe pre-eclampsia (one patient). Obstetric 
hemorrhage and hypertensive disorders had very low MI of 
1.8% and 1.4%, respectively. 
The mean SI value of MNM patients due to severe ob-
stetric bleeding was 1.36 ± 0.43.
Table 5 presents that 125 patients with MNM underwent 
clinical and surgical interventions. Some MNM patients ex-
perienced more than one intervention. All MNM patients 
were hospitalized in the ICU and followed-up at the ICU until 
their clinical findings improved. Fifty-four patients under-
went ≥five units of red blood cell transfusion, four patients 
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Table 4. The primary diagnoses causing maternal near-miss and maternal deaths
Causes MNM patients (n = 125) Maternal deaths (n = 2) Mortality index 
Obstetric hemorrhages, n (%) 54 (43.2%) 1 (50.0%) 1.8%
Shock index, mean ± std 1.36 ± 0.43 1.74
Hypertensive disorders, n (%) 70 (56.0%) 1 (50%) 1.4%
Severe pre-eclampsia, n (%) 58 (46.4%) 1 1.7%
HELLP, n (%) 9 (7.2%) – –
Eclampsia, n (%) 3 (2.4%) – –
Status epilepticus, n (%) 1 (0.8%) – –
MNM — maternal near-miss
Table 5. Clinical and surgical interventions in maternal near-miss 
patients (n = 125)
Intervention n (%)
ICU admission 125 (100%)
≥ 5 units of red blood cell 54 (43.2%)
Hysterectomy following hemorrhage 4 (3.2%)
Continuous use of vasoactive drugs 2 (1.6%)
Intubation and ventilation 1 (0.8%)
Dialyses for acute renal failure 1 (0.8%)
ICU — intensive care unit
underwent a peripartum hysterectomy, two patients ex-
perienced continuous use of vasoactive drugs, one patient 
underwent intubation and ventilation, and one patient ex-
perienced dialysis for acute renal failure. Also, eight patients 
with severe postpartum bleeding experienced intrauterine 
balloon tamponade, and two of the patients who underwent 
peripartum hysterectomy had simultaneously undergone 
bilateral internal iliac artery ligation.
The mean duration of ICU stay in MNM patients was 
2.6 ± 0.4 days, and the mean length of hospital stay 
was 5.8 ± 0.6 days.
When we examined maternal death cases, one was a se-
vere postpartum hemorrhage patient due to postpartum at-
ony. The SI of this patient was 1.74 and died to hypovolemic 
shock despite massive blood transfusion. The other maternal 
death case had acute respiratory distress syndrome due to 
severe pre-eclampsia.
DISCUSSION
The present study utilised the WHO MNM standard 
audit tool for describing and examining MNM patients, 
as well as calculating proposed indicators. The WHO 
management-based criteria were strictly followed to clas-
sify patients as MNM. However, we modified the WHO 
list of MNM to include the added categories of severe 
pre-eclampsia and eclampsia. Since MNM patients are 
related predominantly to organ system dysfunction, and 
pre-eclampsia/eclampsia are spread across multiple or-
gan systems, the WHO audit tool cannot define the exact 
rate of MNM patients. 
The MNM ratio may vary due to the wide variation in 
the identification of MNM patients. Also, the MNM ratio 
is higher in low- and middle-income countries [15]. This 
study revealed the incidence of MNM to be 5.03/1000 live 
births, which is comparable to studies in Australia and the 
Netherlands, with rates of 7.0, and 7.1, respectively [16, 17]. 
In a study conducted by Nelissen et al. [18], the MNM ratio 
in Tanzania was much higher when compared to our study, 
which reported 23.6/1000 live births. However, our MNM 
ratio was higher than in various high-income countries, in-
cluding Scotland, the UK and Canada, where the MNM ratio 
was 1.34, 1.2, and 0.7, respectively [19]. This result could be 
explained firstly by the fact that we have a less-developed 
health system; secondly, we used a more comprehensive 
description of MNM, which involved severe pre-eclampsia 
and eclampsia patients. 
This study found that hypertensive disorders and ob-
stetric hemorrhages were frequent contributors to MNM, 
consistent with the literature [20]. Also, these leading 
underlying causes are similar to the top causes of MM. 
This similarity proves that the concept of MNM can be 
a placeholder for MM. The MM ratio in our study was 8.1 per 
100 000 live births, which is lower than the national level of 
14.7 per 100 000 live births, and lower from worldwide [4]. 
The ratio of MNM patients to MM was 62.4 to 1. This ratio 
was 49 to 1 in Scotland, 53 to 1 in the Netherlands, and 
117 to 1 in the UK [17, 19]. Therefore, for studies attempting 
to confirm a notable improvement in outcomes by interven-
tion, the number of subjects required to show a notable 
difference with MNM as an outcome would be much less 
than if MM only was the outcome [6]. Also, the higher ratio 
of MNM events to MM indicates better quality of care. This 
ratio was observed to be lower in poor resource settings 
in Asia and Africa when compared to high-income coun-
tries [19]. In an Indian study conducted by Abha et al. [21], 
this ratio was 2 to 1. 
304
Ginekologia Polska 2021, vol. 92, no. 4
www. journals.viamedica.pl/ginekologia_polska
The overall MI was 1.57%, which is comparable to the 
studies from developed countries [19]. The MI was 1.8% for 
obstetric hemorrhages, and 1.4% for hypertensive disor-
ders. The lower MIs for MNM patients in our hospital indi-
cates the quality of maternal care and a functional health 
system. The WHO reported that obstetric hemorrhage was 
the leading cause, with postpartum hemorrhage (PPH) ac-
counting for 2/3 of all maternal deaths. Severe PPH may 
cause to multiorgan dysfunction and requires multidisci-
plinary strategies in well-resourced units. The availability 
of uterotonics, blood and blood products, and interven-
tions to end hemorrhage are crucial to improving standards 
of maternal health care [22]. Tahaoğlu et al. reported that 
the incidence of emergency peripartum hysterectomy was 
0.77 per l000 live births in the same population in 2013 [23]. 
In this study, the incidence was 3.2% in MNM patients. Also, 
previous researches have reported a higher case mortality 
rate of hypertensive disorders, and was stated to be due 
to insufficient management of these cases [8]. In our clini-
cal protocol, all MNM patients with hypertensive disorders 
received Magnesium sulphate treatment in ICU. The ICU 
follow-up rate among MNM patients is low, and most deaths 
occurred without being accepted into ICU [8]. Otherwise, 
in this study, there were no patients with puerperal sepsis, 
which has been responsible as many as 30% of maternal 
deaths in low and middle-income countries [20]. 
The hemodynamic changes of gestation may mask the 
impending hypovolemic shock, causes conventional vital 
signs to be less helpful, and signs taken in isolation may 
neglect impending deterioration [14]. Lee et al. [24] reported 
that a shock index higher than 0.9 had high sensitivity and 
specificity for prediction of massive transfusion and invasive 
procedures. El Ayadi et al. [14] recommended a shock index 
threshold of ≥ 1.4 indicating an urgent need for intervention, 
and ≥ 1.7 indicating a high risk of adverse outcome. In this 
study, the SI of MNM patients with obstetric hemorrhage 
was 1.36 ± 0.43, and the SI of the patient who died due to 
PPH was 1.74. 
There are some limitations to this study. This study has 
been designed retrospectively and has the potential to con-
tain limitations of such studies. Because of the dependence 
on information reported in the patient record, we could 
not identify risk factors for all MNM patients. The study 
was conducted for a one-year duration, so the number of 
patients were not adequate to conclude the less frequent 
causes of MNM. Our hospital is a tertiary referral center, and 
the hospital-based data might have cause to overestimating 
MNM and MM ratios due to the concentration of referral 
MNM events. Nevertheless, we can say that this bias may 
affect the MI to a lesser extent considering that most women 
with MNM are treated in hospitals. 
CONCLUSION
The MNM rates and MM rates in our hospital were higher 
than high-income countries but were lower than in low- 
and middle-income countries. Hypertensive disorders and 
obstetric hemorrhage were the leading conditions related 
to MNM and MM. However, the MIs for these causes were 
low, reflecting the good quality of maternal care and well-re-
sourced units. Adopting the MNM concept into the health 
system and use as an indicator for evaluating maternal 
health facilities is crucial to prevent MM. 
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